Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Regeneron Pharmaceuticals	REGN	15. nov 2024	756.81	-3.28
REGENXBIO	RGNX	15. nov 2024	9.63	-13.55
Regional Health Properties	RHE	15. nov 2024	1.57	+12.14
Regional Health Properties A Pref	RHE-A	15. nov 2024	0.45	0.00
Regional Management	RM	15. nov 2024	29.67	-0.20
Regions Financial	RF	15. nov 2024	26.36	+0.34
Regions Financial B Pref	RF-B	15. nov 2024	24.98	0.00
Regions Financial C Pref	RF-C	15. nov 2024	24.56	+0.45
Regions Financial E Pref	RF-E	15. nov 2024	19.40	0.00
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F	RF-F	15. nov 2024	26.01	0.00
Regis	RGS	15. nov 2024	17.36	-3.56
Regulus Therapeutics	RGLS	15. nov 2024	1.43	-4.67
Reinsurance Group of America	RGA	15. nov 2024	231.95	+1.06
REIT Index ETF Vanguard	VNQ	15. nov 2024	93.80	+0.05
Reitar Logtech	RITR	15. nov 2024	4.00	0.00
Rekor Systems	REKR	15. nov 2024	0.90	-17.13
Relay Therapeutics	RLAY	15. nov 2024	5.11	-8.84
Reliance	RS	15. nov 2024	310.44	+0.15
Reliance Global	RELI	15. nov 2024	1.45	-8.81
Relmada Therapeutics	RLMD	15. nov 2024	3.01	-4.75
RELX ADR	RELX	15. nov 2024	44.45	-3.26
Remitly Global	RELY	15. nov 2024	19.64	-0.96
Renaissance Ipo ETF	IPO	15. nov 2024	44.31	-2.16
RenaissanceRe	RNR	15. nov 2024	260.18	+1.25
RenaissanceRe G Pref	RNR-G	15. nov 2024	18.10	0.00
RenaissanceRe Holding F Pref	RNR-F	15. nov 2024	24.43	+0.04
Renalytix ADR	RNLX	15. nov 2024	0.20	0.00
Renasant	RNST	15. nov 2024	36.91	+0.44
ReNew Energy Global A Shares	RNW	15. nov 2024	5.39	+0.94
Renn Fund	RCG	15. nov 2024	2.31	-2.32

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.